Boston Scientific (BSX) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 2 518 | 2 741 | 3 453 | 3 938 | 5 102 | 4 763 | ||
| Changes by years, y/y, % | +67% | +9% | +26% | +14% | +30% | +27.6% | |||
Boston Scientific. EBITDA US GAAP, bln rub
Boston Scientific. EBITDA US GAAP, changes, %
Boston Scientific. EBITDA US GAAP, sum by quarters, bln rub
Boston Scientific (BSX) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 1 217 | 1 367 | 1 368 | 956.0 | 1 603 | 4 763 | |
| Changes by years, y/y, % | +24% | +68% | +29% | -11% | +32% | |||
| Changes by quarters, q/q, % | +14% | +12% | +0% | -30% | +68% | |||